-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Arcturus Therapeutics Holdings Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2024.
- Arcturus Therapeutics Holdings Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $10.1 M, a 23.3% increase year-over-year.
- Arcturus Therapeutics Holdings Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $36.6 M, a 16.3% increase year-over-year.
- Arcturus Therapeutics Holdings Inc. annual Share-based Payment Arrangement, Expense for 2023 was $34.6 M, a 13.2% increase from 2022.
- Arcturus Therapeutics Holdings Inc. annual Share-based Payment Arrangement, Expense for 2022 was $30.6 M, a 5.87% increase from 2021.
- Arcturus Therapeutics Holdings Inc. annual Share-based Payment Arrangement, Expense for 2021 was $28.9 M, a 327% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)